Last updated: July 17, 2026

Application No. 18/567,763

GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY

Non-Final OA

Filed

Dec 06, 2023

Priority

Jun 07, 2021 — provisional 63/197,976 +1 more

Examiner

VYAS, KEYUR ANILKUMAR

Art Unit

Tech Center

Assignee

University of Florida Research Foundation Inc.

OA Round

1 (Non-Final)

This examiner grants 52% of cases after interview

— +66.0% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 71 resolved cases, 2023–2026

Examiner Intelligence

VYAS, KEYUR ANILKUMAR View full profile →

Grants 52% of resolved cases

Career Allowance Rate

37 granted / 71 resolved

-7.9% vs TC avg

Strong +66% interview lift

Without

With

+66.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 7m

Avg Prosecution

38 currently pending

Career history

117

Total Applications

across all art units

Statute-Specific Performance

§101

1.7%

-38.3% vs TC avg

§103

51.1%

+11.1% vs TC avg

§102

10.8%

-29.2% vs TC avg

§112

8.0%

-32.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 71 resolved cases

Prosecution Timeline

Dec 06, 2023

Application Filed

May 19, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/820,096

Patent 12648958

TREM COMPOSITIONS AND USES THEREOF

1y 9m to grant Granted Jun 09, 2026

16/734,271

Patent 12630839

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE

6y 4m to grant Granted May 19, 2026

18/341,512

Patent 12624356

COMPOUNDS AND METHODS FOR MODULATING PLP1

2y 10m to grant Granted May 12, 2026

17/849,382

Patent 12612626

An siRNA compound that inhibits expression of APOC3

3y 10m to grant Granted Apr 28, 2026

17/867,404

Patent 12600967

An siRNA compound that inhibits complement factor B (CFB).

3y 9m to grant Granted Apr 14, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

52%

Grant Probability

99%

With Interview (+66.0%)

3y 7m (~11m remaining)

Median Time to Grant

Low

PTA Risk

Based on 71 resolved cases by this examiner. Grant probability derived from career allowance rate.